Moonlake Immunotherapeutics
(MLTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MLTX | URGN | GERN | ||
| Company | Moonlake Immunotherapeutics | Urogen Pharma Ltd | Geron Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 15.50 | 21.24 | 1.5300 | ||
| High | 15.87 | 21.80 | 1.6275 | ||
| Low | 15.23 | 20.94 | 1.5100 | ||
| Latest | 15.58 | 21.64 | 1.5750 | ||
| Change | +0.07 | +0.29 | +0.0450 | ||
| % Change | +0.45% | +1.36% | +2.94% | ||
| Volume | 367,466 | 149,455 | 10,212,184 | ||
| 20-Day Average Volume | 1,630,580 | 765,394 | 13,520,672 | ||
| Previous Close | 15.51 | 21.35 | 1.5300 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 16.13 | 20.26 | 1.4013 | ||
| 20-Day Raw Stochastic | 28.18% | 83.37% | 82.43% | ||
| 20-Day Relative Strength | 51.69 | 51.09 | 62.58 | ||
| Weighted Alpha | +61.96 | +56.47 | -12.01 | ||
| Today's Opinion | 40% Sell | 40% Buy | 88% Buy | ||
| Previous Opinion | 56% Sell | 40% Buy | 88% Buy | ||
| Last Month's Opinion | 56% Sell | 72% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.63% since 02/02/26 | +9.29% since 02/02/26 | +1.62% since 02/02/26 | ||
| Low | 14.47 on 02/04/26 | 19.13 on 02/03/26 | 1.4500 on 02/05/26 | ||
| High | 16.16 on 02/03/26 | 22.21 on 02/05/26 | 1.6300 on 02/09/26 | ||
| 1-Month | |||||
| %Chg | -15.14% since 01/09/26 | +1.32% since 01/09/26 | +16.79% since 01/09/26 | ||
| Low | 14.47 on 02/04/26 | 18.12 on 01/14/26 | 1.2600 on 01/20/26 | ||
| High | 18.80 on 01/12/26 | 22.21 on 02/05/26 | 1.6300 on 02/09/26 | ||
| 3-Month | |||||
| %Chg | +47.60% since 11/07/25 | -7.36% since 11/07/25 | +46.26% since 11/07/25 | ||
| Low | 10.52 on 11/10/25 | 18.12 on 01/14/26 | 1.0500 on 11/19/25 | ||
| High | 18.80 on 01/12/26 | 30.00 on 11/26/25 | 1.6300 on 02/09/26 | ||
| 6-Month | |||||
| %Chg | -70.06% since 08/08/25 | +21.33% since 08/08/25 | +22.27% since 08/08/25 | ||
| Low | 5.95 on 09/29/25 | 15.86 on 10/10/25 | 1.0400 on 11/07/25 | ||
| High | 62.75 on 09/26/25 | 30.00 on 11/26/25 | 1.6300 on 02/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 996,223 | 999,372 | 976,683 | ||
| Shares Outstanding, K | 64,231 | 46,809 | 638,355 | ||
| Annual Sales | 0 | 90,400,000 | 76,990,000 | ||
| Annual Net Income | -118,940,000 | -126,870,000 | -174,570,000 | ||
| Last Quarter Sales | 0 | 27,480,000 | 47,230,000 | ||
| Last Quarter Net Income | -69,730,000 | -33,350,000 | -18,430,000 | ||
| 60-Month Beta | 1.21 | 1.32 | 0.62 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.10 on 11/05/25 | -0.69 on 11/06/25 | -0.03 on 11/05/25 | ||
| Latest Earnings Date | 02/25/26 | 03/09/26 | 02/25/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||